In support of this, it was shown that FABP5 induced an increase of proliferation, tumorigenicity and metastasis in prostate cancer, and thus an elevated level of FABP5 has been identified as a poor prognostic indicator in cancers [29,30,31]. This evidence concerns the gene FABP5 and prostate cancer.